Dubai Health Authority, University of Birmingham Dubai partner to develop healthcare sector


DUBAI: The Dubai Health Authority (DHA) and the University of Birmingham Dubai recently signed a Memorandum of Understanding (MoU) to enhance healthcare sector development efforts.

The MoU was signed by Awadh Seghayer Al Ketbi, Director-General of the Dubai Health Authority; and Professor Yusra Mozoughi, Provost of the University of Birmingham Dubai, in the presence of officials and experts.

The MoU marks a significant step in advancing human resources for health and strategic development initiatives. Fourteen employees graduated from the university’s training programme, aligning with global best practices in health systems and policy development.

The memorandum includes various areas of cooperation, focusing on developing health policies and strategies, implementing advanced mechanisms for monitoring, evaluating, and measuring the future impact of policies, as well as exchanging experiences and knowledge.

Additionally, the memorandum covers other important areas such as research and development, training
and talent enhancement, improving investment levels in experiences and human competencies, and other healthcare and specialised fields.

The collaboration between Dubai Health Authority and the University of Birmingham extends to organising specialised courses according to the highest standards and modern practices to meet the needs of the Authority’s employees. This collaboration aims to foster a culture of continuous education within the Dubai Health Authority.

Al Ketbi emphasised Dubai Health Authority’s clear policy of collaboration with all local and international health, scientific, and academic institutions, serving the strategic goals of Dubai’s healthcare sector and enhancing opportunities for achieving the highest levels of health welfare.

Fatima Abbas, CEO of the Strategy and Corporate Development Sector at the DHA, said that the partnership with the University of Birmingham will have a significant positive impact on supporting the Authority’s efforts, enhancing its role, and guiding its path tow
ards sustainable health.

Professor Yusra Mouzughi, Provost at the University of Birmingham Dubai, said, “This collaboration delivers on our mission ensuring that we serve the communities in which we operate. We are excited to bring benefit to the health workforce by connecting them to best practices and development through education, research enabling them to become active contributors to the advancement of the latest sector solutions appraising the impact of change in our health systems and policies towards the realisation of universal health coverage and the health-related Sustainable Development Goals.’

Source: Emirates News Agency

Sheikh Shakhbout Medical City inaugurates Centre of Innovation and Medical Simulation


ABU DHABI: Sheikh Shakhbout Medical City, member of the PureHealth network, announced on Tuesday the official opening of its Centre of Innovation and Medical Simulation.

The inauguration was marked by the attendance of dignitaries from Abu Dhabi’s Department of Health, SEHA, and partner university hospitals and represents another milestone achievement in the hospital’s commitment to shaping the future of health care education and setting new benchmarks in the region.

This state-of-the-art facility serves as an advanced medical simulation centre for training health care professionals, including doctors, nurses, allied health workers, and medical students.

Offering a range of advanced educational experiences, the centre is equipped with a variety of simulation facilities covering basic to complex medical scenarios. These include specialised units for adults, paediatrics and a unique pregnant woman simulation unit, providing realistic, hands-on training across various medical pathologies.

Additionally, the c
entre features highly advanced endoscopy and ultrasound simulators, as well as simulated burns and trauma management apparatus.

Dr. Marwan Alkaabi, SSMC’s Acting Chief Executive Officer, said, ‘As a transformation-orientated organisation, SSMC continues to be at the forefront of adopting state-of-the-art technology, key innovative procedures and techniques to improve the overall patient journey.

‘This multidisciplinary educational facility will further enhance SSMC’s reputation for setting benchmarks in education and training standards, fostering excellence and ensuring consistency in patient care and service quality.’

According to Dr. Alkaabi, the hospital’s new simulation facility will also be an immediate benefit for the next generation of health care professionals, with SSMC already collaborating with several prestigious universities and teaching hospital partners, in the UAE.

Dr. Abdulkarim Saleh, Acting Dean of Education at SSMC, said, ‘The Centre of Innovation and Medical Simulation is a significan
t addition to SSMC, as well as the wider medical community.

‘With an ongoing commitment to developing the UAE’s health care talent, this announcement further demonstrates SSMC’s continuing investment in research, education and development, and wider health care vision for the UAE and region,’ Dr. Saleh concluded.

The inauguration of the centre can be seen as another milestone in support of the hospital’s existing research and educational capabilities and demonstrates a commitment to delivering life-changing advancements for patients in the UAE and beyond.

Source: Emirates News Agency

Tawam hospital restores full mobility in patient with complex elbow fracture


ABU DHABI: The Abu Dhabi Health Services Company (SEHA), a subsidiary of PureHealth, has achieved a medical milestone by successfully performing a pioneering procedure to fully restore the elbow function of a patient who suffered from a complex fracture sustained in a car accident.

The surgery took place at Tawam Hospital in Al Ain, where a team of leading orthopaedic surgeons conducted a bone graft to fully reconstruct the patient’s elbow joint.

After suffering a severe car accident that resulted in a shattered elbow joint and substantial mobility impairment, the patient was referred to the Orthopaedic Surgery Clinic of Dr. Basel Al Arabid, Consultant Orthopaedic Surgeon HOD, at Tawam Hospital.

The medical team, conducting comprehensive clinical assessments, advanced radiological imaging, and leveraging in-depth case studies, meticulously evaluated the patient’s condition.

The surgical team, led by Dr. Al Arabid and comprising Dr. Wael Tilkh, Consultant Orthopaedic and Joint Surgeon, Dr. Nader Skaal, Spe
cialist in Orthopaedic and Joint Surgery, and Dr. Mohammed Al Rousan, Specialist in Orthopaedic and Joint Surgery, was able to successfully reconstruct the elbow joint, grafting a new bone to replace the shattered one and securing it with specialised titanium plates.

The patient was then placed under the care of physiotherapists and occupational therapists at Tawam Hospital, undergoing extensive physical and functional rehabilitation.

PureHealth and its subsidiaries continue to lead in the adoption of cutting-edge healthcare solutions, advancing the science of longevity, and empowering individuals to lead longer, healthier, happier, and fuller lives.

With a diverse portfolio and a robust network of hospitals, clinics, multiple diagnostic centres, insurance solutions, pharmacies, health tech and procurement, PureHealth is at the forefront of revolutionising healthcare systems.

Source: Emirates News Agency

Tawam hospital restores full mobility in patient with complex elbow fracture


ABU DHABI: The Abu Dhabi Health Services Company (SEHA), a subsidiary of PureHealth, has achieved a medical milestone by successfully performing a pioneering procedure to fully restore the elbow function of a patient who suffered from a complex fracture sustained in a car accident.

The surgery took place at Tawam Hospital in Al Ain, where a team of leading orthopaedic surgeons conducted a bone graft to fully reconstruct the patient’s elbow joint.

After suffering a severe car accident that resulted in a shattered elbow joint and substantial mobility impairment, the patient was referred to the Orthopaedic Surgery Clinic of Dr. Basel Al Arabid, Consultant Orthopaedic Surgeon HOD, at Tawam Hospital.

The medical team, conducting comprehensive clinical assessments, advanced radiological imaging, and leveraging in-depth case studies, meticulously evaluated the patient’s condition.

The surgical team, led by Dr. Al Arabid and comprising Dr. Wael Tilkh, Consultant Orthopaedic and Joint Surgeon, Dr. Nader Skaal, Spe
cialist in Orthopaedic and Joint Surgery, and Dr. Mohammed Al Rousan, Specialist in Orthopaedic and Joint Surgery, was able to successfully reconstruct the elbow joint, grafting a new bone to replace the shattered one and securing it with specialised titanium plates.

The patient was then placed under the care of physiotherapists and occupational therapists at Tawam Hospital, undergoing extensive physical and functional rehabilitation.

PureHealth and its subsidiaries continue to lead in the adoption of cutting-edge healthcare solutions, advancing the science of longevity, and empowering individuals to lead longer, healthier, happier, and fuller lives.

With a diverse portfolio and a robust network of hospitals, clinics, multiple diagnostic centres, insurance solutions, pharmacies, health tech and procurement, PureHealth is at the forefront of revolutionising healthcare systems.

Source: Emirates News Agency

Pfizer unveils new treatment for alopecia areata in UAE


DUBAI: Pfizer announced today a groundbreaking advancement in treating severe alopecia areata in the UAE for patients as young as 12 years old.

This new once-daily oral capsule is an important milestone offering hope for patients living with the challenges brought by this autoimmune disease.

Dr. Fatima Albreiki, Scientific Committee Chairperson at Emirates Dermatology Society, said, “I believe in advancing therapies that not only address the physical manifestations but also the emotional impact of hair loss. Introducing this treatment in the UAE marks a promising advancement in treatment options for patients, potentially transforming the lives of those affected.”

Serhat Yalcinkaya, Pfizer’s Gulf Cluster Lead, said, “This new advancement in the treatment of severe Alopecia Areata is an important milestone for patients as young as 12 years of age.”

Source: Emirates News Agency